Clinical Trial

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-09-16; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Recruiting 2024-10-30
Trial Details
NCT Number NCT06598397
Lead Sponsor New York University
Collaborators: National Cancer Institute (NCI)
Conditions Human Immunodeficiency Virus (HIV), Smoking Cessation
Enrollment 500 participants
Start Date 2024-10-18
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-13